Guanze Intelligent Medical Information Industry Holding Co. Ltd. reported a 20.3% decrease in total revenue for the six months ended 30 June 2024, with revenue falling to RMB31.9 million from RMB40.0 million in the same period last year. The decline was primarily attributed to a decrease in revenue from the sales of medical imaging film products. The company's revenue is derived from the sales of medical imaging film products and software, as well as the provision of medical imaging cloud services in Mainland China. There was no mention of a material adverse change in the market conditions or the industry environment that would affect the company's financial and operating position during the reporting period. The company also highlighted the continued use of net proceeds from its recent global offering, noting that funds are allocated toward working capital and other general corporate purposes. No significant operational or business changes were reported, and the company emphasized its ongoing research and development efforts as a key factor for future growth and development.